We are a specialty pharmaceutical company focused on developing and commercializing a portfolio of novel non-opioid, pain management therapies to address unmet medical needs and improve patients’ quality of life. Our first commercial product, Qutenza, became commercially available in the United States and in certain European countries in the first half of 2010. Qutenza is a dermal delivery system designed to topically administer capsaicin to treat certain neuropathic pain conditions and was approved by the FDA in November 2009 for the management of neuropathic pain associated with postherpetic neuralgia, or PHN. Qutenza is also approved in the European Union for the treatment of peripheral neuropathic pain in non-diabetic adults. Qutenza is the first prescription strength capsaicin product approved in the United States.
Company profile
Ticker
NGSX
Exchange
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
SEC CIK
Corporate docs
IRS number
943307935
Latest filings (excl ownership)
8-K
Entry into a Material Definitive Agreement
11 Jul 13
8-K
Submission of Matters to a Vote of Security Holders
24 Jun 13
8-K
Entry into a Material Definitive Agreement
17 Apr 13
8-K
Entry into a Material Definitive Agreement
1 Apr 13
NT 10-K
Notice of late annual filing
1 Apr 13
8-K
Other Events
27 Mar 13
EFFECT
Notice of effectiveness
26 Mar 13
EFFECT
Notice of effectiveness
26 Mar 13
EFFECT
Notice of effectiveness
26 Mar 13
EFFECT
Notice of effectiveness
26 Mar 13
Latest ownership filings
SC 13G/A
NeurogesX Inc
13 Feb 17
SC 13G/A
NeurogesX Inc
9 Feb 17
SC 13G/A
NeurogesX Inc
17 Feb 16
SC 13G/A
NeurogesX Inc
11 Feb 16
SC 13G
NeurogesX Inc
7 Jan 16
SC 13G/A
NeurogesX Inc
18 Sep 15
SC 13G
NeurogesX Inc
17 Sep 15
SC 13G
NeurogesX Inc
10 Feb 15
SC 13G/A
NeurogesX Inc
18 Feb 14
SC 13D/A
ARCH VENTURE FUND V LP
4 Aug 11
Institutional ownership, Q2 2020
13F holders | Current |
---|---|
Total holders | 1 |
Opened positions | 0 |
Closed positions | 0 |
Increased positions | 0 |
Reduced positions | 0 |
13F shares | Current |
---|---|
Total value | 0.00 |
Total shares | 100.00 |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
Orion Portfolio Solutions | 100.00 | $0.00 |